治疗患有注意力缺陷多动障碍（ADHD）的儿童和青少年时的药物治疗选择：解读2006年英国国家卫生与临床优化研究所（NICE）指南
Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
作者信息
Harpin V A
机构信息
Ryegate Childrens Centre, Sheffield Children's NHS Foundation Trust, Tapton Crescent Road, Sheffield S10 5DD, UK.
出版信息
Arch Dis Child Educ Pract Ed. 2008 Apr;93(2):58-65. doi: 10.1136/adc.2006.106864.
In recent years the medication options for the treatment of ADHD in children and young people have increased. The National Institute for Health and Clinical Excellence (NICE) produced updated guidelines in 2006. This paper aims to interpret these guidelines by reviewing the medication options in light of relevant research and clinical practice. The properties of methylphenidate, dexamfetamine and atomoxetine are discussed.
近年来，治疗儿童和青少年注意力缺陷多动障碍（ADHD）的药物选择有所增加。英国国家卫生与临床优化研究所（NICE）于2006年制定了更新后的指南。本文旨在通过结合相关研究和临床实践回顾药物选择来解读这些指南。文中讨论了哌甲酯、右旋苯丙胺和托莫西汀的特性。
Zotero 插件